Search Orphan Drug Designations and Approvals
-
| Generic Name: | A potent negative allosteric modulator (NAM) of human alpha5-GABAA receptor |
|---|---|
| Date Designated: | 01/31/2024 |
| Orphan Designation: | Treatment of trigeminal neuralgia |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Shanghai SIMR Biotechnology Co., Ltd. Building 26, 100 Banxia Road Pudong New District Shanghai, Shanghai 201318 China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







